Global Neuromyelitis Optica Drug Industry 2016 Deep Market Research Report

1 Industry Overview 1

1.1 Definition and Specifications of Neuromyelitis Optica Drug 1

1.1.1 Definition of Neuromyelitis Optica Drug 1

1.1.2 Specifications of Neuromyelitis Optica Drug 2

1.2 Classification of Neuromyelitis Optica Drug 2

1.2.1 Glucocorticoids 3

1.2.2 Immunoglobulin 4

1.3 Applications of Neuromyelitis Optica Drug 5

1.3.1 Acute attack 5

1.3.2 Remission prophylactic treatment 6

1.4 Industry Chain Structure of Neuromyelitis Optica Drug 8

1.5 Industry Overview and Major Regions Status of Neuromyelitis Optica Drug 8

1.5.1 Industry Overview of Neuromyelitis Optica Drug 8

1.5.2 Global Major Regions Status of Neuromyelitis Optica Drug 9

1.6 Industry Policy Analysis of Neuromyelitis Optica Drug 9

1.7 Industry News Analysis of Neuromyelitis Optica Drug 10

2 Manufacturing Cost Structure Analysis of Neuromyelitis Optica Drug 12

2.1 Raw Material Suppliers Analysis of Neuromyelitis Optica Drug 12

2.2 Equipment Suppliers Analysis of Neuromyelitis Optica Drug 12

2.3 Labor Cost Analysis of Neuromyelitis Optica Drug 13

2.4 Other Costs Analysis of Neuromyelitis Optica Drug 16

2.5 Manufacturing Cost Structure Analysis of Neuromyelitis Optica Drug 16

2.6 Manufacturing Process Analysis of Neuromyelitis Optica Drug 17

3 Technical Data and Manufacturing Plants Analysis 18

3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2015 18

3.2 Manufacturing Plants Distribution of Global Key Neuromyelitis Optica Drug Manufacturers in 2015 18

3.3 R&D Status and Technology Source of Global Neuromyelitis Optica Drug Key Manufacturers in 2015 19

4 Capacity, Production and Revenue Analysis of Neuromyelitis Optica Drug by Regions, Types and Manufacturers 20

4.1 Global Capacity, Production and Revenue of Neuromyelitis Optica Drug by Regions 2011-2016 20

4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Neuromyelitis Optica Drug 2011-2016 24

4.3 Global Capacity, Production and Revenue of Neuromyelitis Optica Drug by Types 2011-2016 31

4.4 Global Capacity, Production and Revenue of Neuromyelitis Optica Drug by Manufacturers 2011-2016 35

5 Price, Cost, Gross and Gross Margin Analysis of Neuromyelitis Optica Drug by Regions, Types and Manufacturers 42

5.1 Price, Cost, Gross and Gross Margin Analysis of Neuromyelitis Optica Drug by Regions 2011-2016 42

5.2 Price, Cost, Gross and Gross Margin Analysis of Neuromyelitis Optica Drug by Types 2011-2016 45

5.3 Price, Cost, Gross and Gross Margin Analysis of Neuromyelitis Optica Drug by Manufacturers 2011-2016 47

6 Consumption Volume, Consumption Value and Sale Price Analysis of Neuromyelitis Optica Drug by Regions, Types and Applications 52

6.1 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Regions 2011-2016 52

6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Neuromyelitis Optica Drug 2011-2016 55

6.3 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Types 2011-2016 60

6.4 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Applications 2011-2016 63

6.5 Sale Price of Neuromyelitis Optica Drug by Regions 2011-2016 66

6.6 Sale Price of Neuromyelitis Optica Drug by Types 2011-2016 66

6.7 Sale Price of Neuromyelitis Optica Drug by Applications 2011-2016 66

7 Supply, Import, Export and Consumption Analysis of Neuromyelitis Optica Drug 67

7.1 Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 67

7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 68

7.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 69

7.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 70

7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 70

7.6 Asia (Ex China) Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 71

8 Analysis of Neuromyelitis Optica Drug Industry Key Manufacturers 73

8.1 Pfizer 73

8.1.1 Company Profile 73

8.1.2 Product Information 74

8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 74

8.2 Fresenius 76

8.2.1 Company Profile 76

8.2.2 Product Information 77

8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 78

8.3 TEVA 80

8.3.1 Company Profile 80

8.3.2 Product Information 81

8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 81

8.4 Sandoz 83

8.4.1 Company Profile 83

8.4.2 Product Information 84

8.4.3 Capacity, Production, Price, Cost, Gross, and Revenue 84

8.5 Intas 86

8.5.1 Company Profile 86

8.5.2 Product Information 87

8.5.3 Capacity, Production, Price, Cost, Gross, and Revenue 87

8.6 Gyjtrs 89

8.6.1 Company Profile 89

8.6.2 Product Information 90

8.6.3 Capacity, Production, Price, Cost, Gross, and Revenue 90

8.7 Nang Kuang 92

8.7.1 Company Profile 92

8.7.2 Product Information 93

8.7.3 Capacity, Production, Price, Cost, Gross, and Revenue 93

8.8 Tianjin Kingyork 95

8.8.1 Company Profile 95

8.8.2 Product Information 96

8.8.3 Capacity, Production, Price, Cost, Gross, and Revenue 96

8.9 Baxter 98

8.9.1 Company Profile 98

8.9.2 Product Picture and Specifications 99

8.9.3 Capacity, Production, Price, Cost, Gross, and Revenue 99

8.10 CSL 101

8.10.1 Company Profile 101

8.10.2 Product Picture and Specifications 102

8.10.3 Capacity, Production, Price, Cost, Gross, and Revenue 102

8.11 Grifols 104

8.11.1 Company Profile 104

8.11.2 Product Picture and Specifications 105

8.11.3 Capacity, Production, Price, Cost, Gross, and Revenue 107

8.12 Octapharma 108

8.12.1 Company Profile 108

8.12.2 Product Picture and Specifications 109

8.12.3 Capacity, Production, Price, Cost, Gross, and Revenue 109

8.13 CBOP 111

8.13.1 Company Profile 111

8.13.2 Product Picture 112

8.13.3 Capacity, Production, Price, Cost, Gross, and Revenue 112

9 Marketing Trader or Distributor Analysis of Neuromyelitis Optica Drug 114

9.1 Marketing Channels Status of Neuromyelitis Optica Drug 114

9.2 Traders or Distributors with Contact Information of Neuromyelitis Optica Drug by Regions 114

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Neuromyelitis Optica Drug 116

9.4 Regional Import, Export and Trade Analysis of Neuromyelitis Optica Drug 116

10 Industry Chain Analysis of Neuromyelitis Optica Drug 118

10.1 Major Raw Materials Suppliers with Contact Information Analysis of Neuromyelitis Optica Drug 118

10.2 Major Equipment Suppliers with Contact Information Analysis of Neuromyelitis Optica Drug 119

10.3 Major Consumers with Contact Information Analysis of Neuromyelitis Optica Drug 119

10.4 Supply Chain Relationship Analysis of Neuromyelitis Optica Drug 121

11 Development Trend of Analysis of Neuromyelitis Optica Drug 122

11.1 Capacity, Production and Revenue Forecast of Neuromyelitis Optica Drug by Regions and Types 122

11.1.1 Global Capacity, Production and Revenue of Neuromyelitis Optica Drug by Regions 2016-2021 122

11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Neuromyelitis Optica Drug 2016-2021 126

11.1.3 Global Capacity, Production and Revenue of Neuromyelitis Optica Drug by Types 2016-2021 133

11.2 Consumption Volume and Consumption Value Forecast of Neuromyelitis Optica Drug by Regions, Types and Applications 137

11.2.1 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Regions 2016-2021 137

11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Neuromyelitis Optica Drug 2016-2021 140

11.2.3 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Types 2016-2021 145

11.2.4 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Applications 2016-2021 148

11.3 Supply, Import, Export and Consumption Forecast of Neuromyelitis Optica Drug 151

11.3.1 Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 151

11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 152

11.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 153

11.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 153

11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 154

11.3.6 Asia (Ex China) Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 155

12 New Project Investment Feasibility Analysis of Neuromyelitis Optica Drug 156

12.1 New Project SWOT Analysis of Neuromyelitis Optica Drug 156

12.2 New Project Investment Feasibility Analysis of Neuromyelitis Optica Drug 156

12.2.1 Project Name 156

12.2.2 Investment Budget 157

12.2.3 Project Product Solutions 157

12.2.4 Project Schedule 157

13 Conclusion of the Global Neuromyelitis Optica Drug Industry 2016 Market Research Report 159

Figure Picture of Neuromyelitis Optica Drug 1

Table Comparison of Main Models from Neuromyelitis Optica Drug Major Manufacturers 2

Table Specification Comparison of Different Types of Neuromyelitis Optica Drug 2

Figure Global Production Market Share of Neuromyelitis Optica Drug by Type in 2015 3

Figure Glucocorticoids Picture 3

Table Major Manufacturers of Glucocorticoids 4

Figure Immunoglobulin Picture 4

Table Major Manufacturers of Immunoglobulin 4

Table Applications of Neuromyelitis Optica Drug 5

Figure 2015 Global Neuromyelitis Optica Drug Major Applications Sales Share 5

Figure Acute attack Examples 6

Table Major Consumers of Acute attack 6

Figure Remission prophylactic treatment Examples 7

Table Major Consumers of Remission prophylactic treatment 7

Figure Industry Chain Structure of Neuromyelitis Optica Drug 8

Table Global Neuromyelitis Optica Drug Major Manufacturers 8

Table Global Major Regions Neuromyelitis Optica Drug Development Status in 2015 9

Table Industry Policy of Neuromyelitis Optica Drug 9

Table Industry News List of Neuromyelitis Optica Drug 10

Table Raw Material Suppliers Analysis 11

Table Equipment Suppliers Analysis 11

Figure 2014 APAC Overview of Average Monthly Labor Cost 12

Figure 2014 Americas Overview of Average Monthly Labor Cost 13

Figure 2014 EMEA Overview of Average Monthly Labor Cost 13

Figure 2010-2015 USA Employment Cost Index (ECI) 14

Figure 2010-2014 China Average Wage of Worker and Growth Rate (CNY/a) 14

Table Manufacturing Cost Structure Analysis of Neuromyelitis Optica Drug in 2015 15

Figure Manufacturing Process Analysis of Neuromyelitis Optica Drug 16

Table Capacity (K Units) and Commercial Production Date of Global Neuromyelitis Optica Drug Key Manufacturers in 2015 17

Table Manufacturing Plants Distribution of Global Neuromyelitis Optica Drug Major Manufacturers in 2015 17

Table R&D Status and Technology Source of Global Neuromyelitis Optica Drug Key Manufacturers in 2015 18

Table Global Capacity (K Units) of Neuromyelitis Optica Drug by Regions 2011-2016 19

Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Regions in 2011 19

Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Regions in 2015 20

Table Global Production (K Units) of Neuromyelitis Optica Drug by Regions 2011-2016 20

Figure Global Production Market Share of Neuromyelitis Optica Drug by Regions in 2011 20

Figure Global Production Market Share of Neuromyelitis Optica Drug by Regions in 2015 21

Table Global Revenue (K USD) of Neuromyelitis Optica Drug by Regions 2011-2016 21

Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Regions in 2011 22

Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Regions in 2015 22

Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 23

Figure Global Capacity Utilization Rate of Neuromyelitis Optica Drug 2011-2016 23

Figure Global Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 24

Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 24

Figure North America Capacity Utilization Rate of Neuromyelitis Optica Drug 2011-2016 25

Figure North America Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 25

Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 26

Figure Europe Capacity Utilization Rate of Neuromyelitis Optica Drug 2011-2016 26

Figure Europe Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 27

Figure China Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 27

Figure China Capacity Utilization Rate of Neuromyelitis Optica Drug 2011-2016 28

Figure China Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 28

Figure Asia (Ex China) Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 29

Figure Asia (Ex China) Capacity Utilization Rate of Neuromyelitis Optica Drug 2011-2016 29

Figure Asia (Ex China) Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 30

Table Global Capacity (K Units) of Neuromyelitis Optica Drug by Types 2011-2016 30

Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Types in 2011 31

Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Types in 2015 31

Table Global Production (K Units) of Neuromyelitis Optica Drug by Types 2011-2016 31

Figure Global Production Market Share of Neuromyelitis Optica Drug by Types in 2011 32

Figure Global Production Market Share of Neuromyelitis Optica Drug by Types in 2015 32

Table Global Revenue (K USD) of Neuromyelitis Optica Drug by Types 2011-2016 33

Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Types in 2011 33

Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Types in 2015 34

Table Global and Major Manufacturers Capacity (K Units) of Neuromyelitis Optica Drug 2011-2016 34

Table Global Capacity Market Share of Neuromyelitis Optica Drug Major Manufacturers 2011-2016 35

Figure Global Capacity Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2011 35

Figure Global Capacity Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2015 36

Table Global and Major Manufacturers Production (K Units) of Neuromyelitis Optica Drug 2011-2016 36

Table Global Production Market Share of Neuromyelitis Optica Drug Major Manufacturers 2011-2016 37

Figure Global Production Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2011 37

Figure Global Production Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2015 38

Table Global and Major Manufacturers Revenue (K USD) of Neuromyelitis Optica Drug 2011-2016 38

Table Global Revenue Market Share of Neuromyelitis Optica Drug Major Manufacturers 2011-2016 39

Figure Global Revenue Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2011 39

Figure Global Revenue Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2015 40

Table Price (USD/Unit) of Neuromyelitis Optica Drug by Regions 2011-2016 41

Figure Price (USD/Unit) of Neuromyelitis Optica Drug by Regions in 2015 41

Table Cost (USD/Unit) of Neuromyelitis Optica Drug by Regions 2011-2016 41

Figure Cost (USD/Unit) of Neuromyelitis Optica Drug by Regions in 2015 42

Table Gross (USD/Unit) of Neuromyelitis Optica Drug by Regions 2011-2016 42

Figure Gross (USD/Unit) of Neuromyelitis Optica Drug by Regions in 2015 43

Table Gross Margin of Neuromyelitis Optica Drug by Regions 2011-2016 43

Figure Gross Margin of Neuromyelitis Optica Drug by Regions in 2015 43

Table Price (USD/Unit) of Neuromyelitis Optica Drug by Types 2011-2016 44

Figure Price (USD/Unit) of Neuromyelitis Optica Drug by Types in 2015 44

Table Cost (USD/Unit) of Neuromyelitis Optica Drug by Types 2011-2016 44

Figure Cost (USD/Unit) of Neuromyelitis Optica Drug by Types in 2015 45

Table Gross (USD/Unit) of Neuromyelitis Optica Drug by Types 2011-2016 45

Figure Gross (USD/Unit) of Neuromyelitis Optica Drug by Types in 2015 45

Table Gross Margin of Neuromyelitis Optica Drug by Types 2011-2016 45

Figure Gross Margin of Neuromyelitis Optica Drug by Types in 2015 46

Table Price (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers 2011-2016 46

Figure Price (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers in 2015 47

Table Cost (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers 2011-2016 47

Figure Cost (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers in 2015 48

Table Gross (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers 2011-2016 48

Figure Gross (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers in 2015 49

Table Gross Margin of Neuromyelitis Optica Drug by Manufacturers 2011-2016 49

Figure Gross Margin of Neuromyelitis Optica Drug by Manufacturers in 2015 50

Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Regions 2011-2016 51

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Regions in 2011 52

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Regions in 2015 52

Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Regions 2011-2016 52

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Regions in 2011 53

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Regions in 2015 53

Figure Global Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 54

Figure Global Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 54

Figure North America Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 55

Figure North America Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 55

Figure Europe Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 56

Figure Europe Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 56

Figure China Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 57

Figure China Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 57

Figure Asia (Ex China) Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 58

Figure Asia (Ex China) Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 58

Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Types 2011-2016 59

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Types in 2011 59

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Types in 2015 60

Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Types 2011-2016 60

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Types in 2011 61

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Types in 2015 61

Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Applications 2011-2016 62

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Applications in 2011 62

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Applications in 2015 63

Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Applications 2011-2016 63

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Applications in 2011 64

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Applications in 2015 64

Table Sale Price (USD/Unit) of Neuromyelitis Optica Drug by Regions 2011-2016 65

Table Sale Price (USD/Unit) of Neuromyelitis Optica Drug by Types 2011-2016 65

Table Sale Price (USD/Unit) of Neuromyelitis Optica Drug by Applications 2011-2016 65

Table Global Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 (K Units) 66

Table North America Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 (K Units) 66

Table Europe Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 (K Units) 66

Table China Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 (K Units) 66

Table Asia (Ex China) Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 (K Units) 67

Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2011-2016 67

Table North America Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2011-2016 68

Table North America Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 (K Units) 68

Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2011-2016 69

Table Europe Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 (K Units) 69

Table China Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2011-2016 69

Table China Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 (K Units) 70

Table Asia (Ex China) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2011-2016 70

Table Asia (Ex China) Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 (K Units) 71

Table Pfizer Company Profile 72

Figure Neuromyelitis Optica Drug Product Picture 73

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Pfizer 2011-2016 73

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Pfizer 2011-2016 74

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Pfizer 2011-2016 74

Table Fresenius Company Profile 75

Figure Neuromyelitis Optica Drug Product Picture of Fresenius 76

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Fresenius 2011-2016 77

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Fresenius 2011-2016 78

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Fresenius 2011-2016 78

Table TEVA Company Profile 79

Figure Neuromyelitis Optica Drug Product Picture 80

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of TEVA 2011-2016 80

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of TEVA 2011-2016 81

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of TEVA 2011-2016 81

Table Sandoz Company Profile 82

Figure Neuromyelitis Optica Drug Product Picture of Sandoz 83

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Sandoz 2011-2016 83

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Sandoz 2011-2016 84

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Sandoz 2011-2016 84

Table Intas Company Profile 85

Figure Neuromyelitis Optica Drug Product Picture of Intas 86

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Intas 2011-2016 86

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Intas 2011-2016 87

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Intas 2011-2016 87

Table Gyjtrs Company Profile 88

Figure Neuromyelitis Optica Drug Product Picture of Gyjtrs 89

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Gyjtrs 2011-2016 89

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Gyjtrs 2011-2016 90

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Gyjtrs 2011-2016 90

Table Nang Kuang Company Profile 91

Figure Neuromyelitis Optica Drug Product Picture of Nang Kuang 92

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Nang Kuang 2011-2016 92

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Nang Kuang 2011-2016 93

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Nang Kuang 2011-2016 93

Table Tianjin Kingyork Company Profile 94

Figure Neuromyelitis Optica Drug Product Picture of Tianjin Kingyork 95

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Tianjin Kingyork 2011-2016 95

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Tianjin Kingyork 2011-2016 96

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Tianjin Kingyork 2011-2016 96

Table Baxter Company Profile List 97

Figure Product Picture of Baxter 98

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin 2011-2016 98

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Baxter 2011-2016 99

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Baxter 2011-2016 99

Table CSL Company Profile List 100

Figure Product Picture of CSL 101

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin 2011-2016 101

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of CSL 2011-2016 102

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of CSL 2011-2016 102

Table Grifols Company Profile List 103

Figure Grifols IVIG Flebogamma® 10% DIF Product 104

Table Grifols IVIG Flebogamma® 10% DIF Packaging Standards 104

Figure Grifols IVIG Flebogamma® 5% DIF Product 105

Table Grifols IVIG Flebogamma® 5% DIF Packaging Standards 105

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin 2011-2016 106

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Grifols 2011-2016 106

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Grifols 2011-2016 107

Table Octapharma Company Profile List 107

Figure Product Picture of Octapharma 108

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin 2011-2016 108

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Octapharma 2011-2016 109

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Octapharma 2011-2016 110

Table CBOP Company Profile List 110

Figure Picture of CBOP 111

Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin 2011-2016 111

Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of CBOP 2011-2016 112

Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of CBOP 2011-2016 112

Figure Marketing Channels of Neuromyelitis Optica Drug 113

Table Traders or Distributors with Contact Information of Neuromyelitis Optica Drug by Regions 113

Figure Ex-work Price, Channel Price and End Buyer Price of Neuromyelitis Optica Drug (USD/Unit) in 2015 115

Table Regional Import, Export, and Trade of Neuromyelitis Optica Drug (K Units) 2011-2016 115

Table Flow of International Trade in 2015 116

Table Major Raw Materials Suppliers with Contact Information of Neuromyelitis Optica Drug 117

Table Major Equipment Suppliers with Contact Information of Neuromyelitis Optica Drug 118

Table Major Consumers with Contact Information of Neuromyelitis Optica Drug 118

Figure Supply Chain Relationship Analysis of Neuromyelitis Optica Drug 120

Table Global Capacity (K Units) of Neuromyelitis Optica Drug by Regions 2016-2021 121

Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Regions in 2016 121

Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Regions in 2021 122

Table Global Production (K Units) of Neuromyelitis Optica Drug by Regions 2016-2021 122

Figure Global Production Market Share of Neuromyelitis Optica Drug by Regions in 2016 123

Figure Global Production Market Share of Neuromyelitis Optica Drug by Regions in 2021 123

Table Global Revenue (K USD) of Neuromyelitis Optica Drug by Regions 2016-2021 123

Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Regions in 2016 124

Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Regions in 2021 124

Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 125

Figure Global Capacity Utilization Rate of Neuromyelitis Optica Drug 2016-2021 125

Figure Global Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 126

Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 126

Figure North America Capacity Utilization Rate of Neuromyelitis Optica Drug 2016-2021 127

Figure North America Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 127

Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 128

Figure Europe Capacity Utilization Rate of Neuromyelitis Optica Drug 2016-2021 128

Figure Europe Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 129

Figure China Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 129

Figure China Capacity Utilization Rate of Neuromyelitis Optica Drug 2016-2021 130

Figure China Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 130

Figure Asia (Ex China) Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 131

Figure Asia (Ex China) Capacity Utilization Rate of Neuromyelitis Optica Drug 2016-2021 131

Figure Asia (Ex China) Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 132

Table Global Capacity (K Units) of Neuromyelitis Optica Drug by Types 2016-2021 132

Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Types in 2016 133

Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Types in 2021 133

Table Global Production (K Units) of Neuromyelitis Optica Drug by Types 2016-2021 133

Figure Global Production Market Share of Neuromyelitis Optica Drug by Types in 2016 134

Figure Global Production Market Share of Neuromyelitis Optica Drug by Types in 2021 134

Table Global Revenue (K USD) of Neuromyelitis Optica Drug by Types 2016-2021 135

Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Types in 2016 135

Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Types in 2021 136

Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Regions 2016-2021 136

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Regions in 2016 137

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Regions in 2021 137

Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Regions 2016-2021 138

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Regions in 2016 138

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Regions in 2021 139

Figure Global Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 139

Figure Global Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 140

Figure North America Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 140

Figure North America Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 141

Figure Europe Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 141

Figure Europe Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 142

Figure China Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 142

Figure China Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 143

Figure Asia (Ex China) Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 143

Figure Asia (Ex China) Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 144

Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Types 2016-2021 144

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Types in 2016 145

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Types in 2021 145

Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Types 2016-2021 145

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Types in 2016 146

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Types in 2021 146

Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Applications 2016-2021 147

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Applications in 2016 147

Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Applications in 2021 148

Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Applications 2016-2021 148

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Applications in 2016 149

Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Applications in 2021 149

Table Global Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 (K Units) 150

Table North America Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 (K Units) 150

Table Europe Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 (K Units) 150

Table China Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 (K Units) 150

Table Asia (Ex China) Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 (K Units) 151

Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2016-2021 151

Table North America Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2016-2021 152

Table North America Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 (K Units) 152

Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2016-2021 152

Table Europe Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 (K Units) 153

Table China Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2016-2021 153

Table China Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 (K Units) 154

Table Asia (Ex China) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2016-2021 154

Table Asia (Ex China) Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 (K Units) 154

Table New Project SWOT Analysis of Neuromyelitis Optica Drug 155

Table Project Appraisal and Financing 156

Table New Project Construction Period 156

Table New Project Investment Feasibility Analysis of Neuromyelitis Optica Drug 156